- Myocardial Infarction Evaluation
- Typical
- Troponin I or Troponin T at presentation and 3 hours later
- May extend Troponin Timing to every 4 to 6 hours for 3 samples
- Trend upward above discriminatory Troponin values suggests acute Myocardial Infarction
- Older protocols using CK and CK-MB have largely been replaced by Troponins
- Initial tests at presentation
- Troponin I or Ultrasensensitive Troponin T
- CK and CK-MB
- Tests at 2-4 hours after initial labs
- Troponin I
- CK and CK-MB
- Interpretation: Case in which acute Myocardial Infarction unlikely
- Initial Ultrasensitive Troponin T negative or
- Second Troponin I negative and CK-MB not increasing
- References
- Weingart in Majoewsky (2012) EM:RAP 12(4): 6-7
- Protocol
- Obtain Troponin at 0 hours, 8 hours and 16 hours
- Primary Cardiac Marker: Specific for cardiac event
- Not useful for monitoring event extension
- Levels stay elevated for 14 days
- Obtain CK-MB at 0 hours, 8 hours, and 16 hours
- Primary purpose: Follow cardiac event extension
- Decreases more rapidly than Troponin after event
- Obtain Troponin at 0 hours, 8 hours and 16 hours
-
Test Sensitivity of combined protocol
- Test Sensitivity: >98% at 8 hours
- Test Specificity: 80 to 95% at 8 hours
- References
- Rises: 3-6 hours (up to 10 hours)
- Peaks: 12-48 hours
- Duration: 4-10 days
- Subunits
- Creatine Phosphokinase (CPK)
- Myoglobin
- Advantage: First Cardiac Marker to increase
- Disadvantage: Poor Specificity (only helps if negative)
- Rises: 1-2 hours
- Peaks: 4-6 hours
- Duration: 1-2 days
- Peaks: 24-36 hours
- Duration: 5 days
- Lactic Dehydrogenase (LDH)
- Peaks: 24-48 hours
- Duration: 14 days
- Predicts adverse events in Unstable Angina
- Morbidity and mortality increase with increased WBCs
- References